DA Davidson initiated coverage on shares of Imperva (NASDAQ:IMPV) in a research report released on Tuesday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $56.00 price objective on the software maker’s stock. DA Davidson also issued estimates for Imperva’s Q1 2019 earnings at $0.02 EPS, Q2 2019 earnings at $0.10 EPS, Q3 2019 earnings at $0.19 EPS and Q4 2019 earnings at $0.32 EPS.
Other equities analysts also recently issued reports about the stock. ValuEngine raised shares of Imperva from a sell rating to a hold rating in a report on Thursday, February 15th. Piper Jaffray raised shares of Imperva from a neutral rating to an overweight rating and set a $52.00 price objective on the stock in a report on Friday, February 9th. JPMorgan Chase downgraded shares of Imperva from a neutral rating to an underweight rating and set a $45.00 price objective on the stock. in a report on Tuesday, December 12th. Morgan Stanley increased their price objective on shares of Imperva from $37.00 to $39.00 and gave the company an underweight rating in a report on Friday, February 9th. Finally, Imperial Capital increased their price objective on shares of Imperva from $50.00 to $55.00 and gave the company an outperform rating in a report on Friday, February 9th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating to the company. The company presently has an average rating of Hold and an average target price of $53.21.
IMPV opened at $46.35 on Tuesday. Imperva has a 52-week low of $37.17 and a 52-week high of $52.40.
In related news, Director Anthony J. Bettencourt sold 66,037 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $46.98, for a total transaction of $3,102,418.26. Following the completion of the sale, the director now directly owns 66,037 shares in the company, valued at $3,102,418.26. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CRO Michael D. Mooney sold 24,454 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $47.18, for a total transaction of $1,153,739.72. Following the sale, the executive now owns 24,454 shares of the company’s stock, valued at $1,153,739.72. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.
A number of institutional investors have recently added to or reduced their stakes in IMPV. SG Americas Securities LLC acquired a new stake in Imperva during the third quarter worth about $134,000. Quadrature Capital Ltd acquired a new stake in Imperva during the fourth quarter worth about $224,000. Koch Industries Inc. acquired a new stake in Imperva during the fourth quarter worth about $229,000. Principal Financial Group Inc. increased its position in Imperva by 51.7% during the third quarter. Principal Financial Group Inc. now owns 7,067 shares of the software maker’s stock worth $307,000 after purchasing an additional 2,409 shares during the last quarter. Finally, Renaissance Group LLC acquired a new stake in Imperva during the fourth quarter worth about $341,000.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.